<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200228046637N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-04-03</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of motor exercises on quality of life, depression and anxiety in women with breast cancer</public_title>
      <acronym></acronym>
      <scientific_title>The effect of motor exercises on quality of life, depression and anxiety in women with breast cancer</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46212</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Subjects are numbered on entry to the treatment center and will be assigned to one of the intervention or control groups using random numbers table and simple randomization method.</study_design>
      <phase>N/A</phase>
      <hc_freetext>breast cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Depression, quality of life and demographic questionnaires will be completed as a pre-test. The written consent of the research firm is obtained from them. Motion training is provided by a research associate (sports medicine specialist).Then a 6-minute walk test is performed for the patients to assess their fitness level and to measure shoulder joint range of motion with goniometer. The exercises that are used are selected in consultation with a specialist in sports medicine and patients. The intervention will then be administered to the patients for a 5-week regular walk and arm movements with pamphlets.Arm exercises begin on the second day after surgery and are performed 3 times a week for 20 minutes each time for 5 weeks. If the patient feels uncomfortable, taking a warm shower before exercise can also reduce joint stiffness and ease. Subjects are told that there is no compulsion to continue activities during the sessions and that they can be discouraged if they experience slight fatigue and unpleasant feelings. After the training, the post-test will also be repeated to assess the difference between the groups and the impact of the interventions. Intervention 2: Control group: First, the goals of the research will be explained to them, and then as a pre-test, they will complete the Depression, Quality of Life and Demographic Questionnaires. Based on the results of the questionnaires and according to the inclusion and exclusion criteria of the eligible people, they are randomly assigned to the control group. They are asked not to participate in any organized exercise program during this time. After 5 weeks, they will be tested again to assess the difference between the groups. At the end of the intervention, participants will be instructed on the ethical considerations of walking and arm movements. And a pamphlet is given to them.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Primary and secondary outcome information is shared anonymously.

When:
Access started 6 months after the results were published.

To whom:
Accessible to all researchers working in academic institutions and specialists in breast surgery

Conditions:
The results of documentation and data can be used for or not to be used on breast surgery patients.

Where to obtain:
The person responsible for the public accountability of the study can provide information to eligible individuals. Fahimeh Qasemi Cherati,
fahime.ghasemi24@gmail.com

How to obtain:
If the person is eligible to request access to the documentation, it will be attempted to provide it as soon as possible after it has been demonstrated that the person is authorized to access the data.

Comments:
I hope that the results of the research will help improve the condition of patients.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fahimeh Ghasemi Cherati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sari-Shahband Street-Vesal square-Nasibeh School of Nursing and Midwifery</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816715793</zip>
        <telephone>+98 11 3379 5555</telephone>
        <email>fahime.ghasemi24@gmail.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Vida  Shafipour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sari-Shahband Street-Vesal square-Nasibeh School of Nursing and Midwifery</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816715793</zip>
        <telephone>+98 11 3379 5555</telephone>
        <email>shafivida@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>women with breast cancer
Non-metastatic
non-postmenopausal
over 18 years of age
at least literate
one or both breast drains
The drain has been removed
no psychological treatment experience
no drug addiction
No heart disease
No respiratory disease
no history of regular physical activity one year prior to the study
patient consent to participate in research
and written consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Subject's unwillingness to continue the intervention
physical disability of the intervention due to treatment periods 
 Unable to walk 
 Unable to stand 
People with a HADS questionnaire score of less than 11.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C50</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant neoplasm of breast</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Depression, quality of life and demographic questionnaires will be completed as a pre-test. The written consent of the research firm is obtained from them. Motion training is provided by a research associate (sports medicine specialist).Then a 6-minute walk test is performed for the patients to assess their fitness level and to measure shoulder joint range of motion with goniometer. The exercises that are used are selected in consultation with a specialist in sports medicine and patients. The intervention will then be administered to the patients for a 5-week regular walk and arm movements with pamphlets.Arm exercises begin on the second day after surgery and are performed 3 times a week for 20 minutes each time for 5 weeks. If the patient feels uncomfortable, taking a warm shower before exercise can also reduce joint stiffness and ease. Subjects are told that there is no compulsion to continue activities during the sessions and that they can be discouraged if they experience slight fatigue and unpleasant feelings. After the training, the post-test will also be repeated to assess the difference between the groups and the impact of the interventions.</i_keyword>
      <i_keyword>Control group: First, the goals of the research will be explained to them, and then as a pre-test, they will complete the Depression, Quality of Life and Demographic Questionnaires. Based on the results of the questionnaires and according to the inclusion and exclusion criteria of the eligible people, they are randomly assigned to the control group. They are asked not to participate in any organized exercise program during this time. After 5 weeks, they will be tested again to assess the difference between the groups. At the end of the intervention, participants will be instructed on the ethical considerations of walking and arm movements. And a pamphlet is given to them.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of Life. Timepoint: Before intervention - 5 weeks later. Method of measurement: 1) QLQ-C30 specific quality of life questionnaire and 2 quality of life questionnaire for breast cancer patients: EORTC QLQ-C23.V.3.</prim_outcome>
      <prim_outcome>Depression and anxiety. Timepoint: Before intervention - 5 weeks later. Method of measurement: HADS Hospital Expression and Anxiety Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Level of physical fitness. Timepoint: Before surgery, after drainage, 5 weeks later. Method of measurement: 6 minute walk test.</sec_outcome>
      <sec_outcome>Joint angles and axis view of joint motion. Timepoint: Goniometer. Method of measurement: Before surgery, after drainage, 5 weeks later.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-12-19</approval_date>
        <contact_name>Imam Educational Hospital of Sari-Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Sari-Shahband Street-Vesal square-Nasibeh School of Nursing and Midwifery Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
